Literature DB >> 16875820

Survival from invasive breast cancer among interval cases in the mammography screening programmes of northern Sweden.

P Bordás1, H Jonsson, L Nyström, P Lenner.   

Abstract

The aim of this study was to estimate breast cancer survival according to detection mode for 5120 women with invasive breast cancer, in particular for those detected in the screening intervals. We found a significant survival difference in favour of women with cancer detected in the screening intervals (n=729) compared with those uninvited (n=1879) during the 13-year follow-up. Detection mode was proven to modify the prognostic effect of stage. Women with stage I interval cancer had shorter survival and those with stage II had longer survival than expected. It is suggested that interval cancers might consist of two subgroups with different behaviour: one of fast-growing tumours presenting as stage I cases and another of slow-growing tumours presenting as stage II+ cases. A hypothesis related to this observation is discussed.

Entities:  

Mesh:

Year:  2006        PMID: 16875820     DOI: 10.1016/j.breast.2006.05.006

Source DB:  PubMed          Journal:  Breast        ISSN: 0960-9776            Impact factor:   4.380


  8 in total

1.  Comparing screening mammography for early breast cancer detection in Vermont and Norway.

Authors:  Solveig Hofvind; Pamela M Vacek; Joan Skelly; Donald L Weaver; Berta M Geller
Journal:  J Natl Cancer Inst       Date:  2008-07-29       Impact factor: 13.506

2.  Using the European guidelines to evaluate the Norwegian Breast Cancer Screening Program.

Authors:  Solveig Hofvind; Berta Geller; Pamela M Vacek; Steinar Thoresen; Per Skaane
Journal:  Eur J Epidemiol       Date:  2007-06-27       Impact factor: 8.082

3.  Could screening participation bias symptom interpretation? An interview study on women's interpretations of and responses to cancer symptoms between mammography screening rounds.

Authors:  Marit Solbjør; John-Arne Skolbekken; Ann Rudinow Sætnan; Anne Irene Hagen; Siri Forsmo
Journal:  BMJ Open       Date:  2012-11-12       Impact factor: 2.692

4.  Prognosis in women with interval breast cancer: population based observational cohort study.

Authors:  Mette Kalager; Rulla M Tamimi; Michael Bretthauer; Hans-Olov Adami
Journal:  BMJ       Date:  2012-11-16

5.  Survival analysis of patients with interval cancer undergoing gastric cancer screening by endoscopy.

Authors:  Chisato Hamashima; Michiko Shabana; Mikizo Okamoto; Yoneatsu Osaki; Takuji Kishimoto
Journal:  PLoS One       Date:  2015-05-29       Impact factor: 3.240

6.  Aggressive primary treatments with favourable 5-year survival for screen-interval breast cancers.

Authors:  Gautier Defossez; Alexandre Quillet; Pierre Ingrand
Journal:  BMC Cancer       Date:  2018-04-06       Impact factor: 4.430

7.  Breast cancer survival and prognosis by screening history.

Authors:  A J Coldman; N Phillips
Journal:  Br J Cancer       Date:  2013-12-03       Impact factor: 7.640

8.  Impact of adjuvant chemotherapy on the survival of patients with breast cancer diagnosed by screening.

Authors:  Irene Zarcos-Pedrinaci; Maximino Redondo; Javier Louro; Francisco Rivas-Ruiz; Teresa Téllez; Diego Pérez; Francisco Medina Cano; Kenza Machan; Laia Domingo; Maria Mar Vernet; Maria Padilla-Ruiz; Xavier Castells; Antonio Rueda; María Sala
Journal:  Cancer Med       Date:  2019-09-24       Impact factor: 4.452

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.